2023 NICE 技术鉴定指导意见：他法西单抗联合来那度胺治疗复发或难治性弥漫性大 B 细胞淋巴瘤[TA883].pdfVIP

Tafasitamabwith

lenalidomidefortreating

relapsedorrefractory

diffuselargeB-cell

lymhoma

Technologyappraisalguidance

Published:3May2023

.uk/guidance/ta883

©NICE2023.Allrightsreserved.SubjecttoNoticeofrights(.uk/terms-and-

conditions#notice-of-rights).

TafasitamabwithlenalidomidefortreatingrelapsedorrefractorydiffuselargeB-cell

lymphoma(TA883)

Yourresponsibility

TherecommendationsinthisguidancerepresenttheviewofNICE,arrivedataftercareful

considerationoftheevidenceavailable.Whenexercisingtheirjudgement,health